Interventional Radiology Imaging

What Is the Initial Therapy for a Right Atrial Thrombus in Transit with Shock?

·
What Is the Initial Therapy for a Right Atrial Thrombus in Transit with Shock?

It is 3 AM in the emergency department when the rapid response team is called for a 65-year-old patient, two days post-orthopedic surgery, who has become acutely short of breath and hypotensive. His blood pressure has been less than 90 mmHg systolic for the last 20 minutes despite a fluid bolus. A point-of-care ultrasound (POCUS) is performed, revealing a dilated right ventricle and, alarmingly, a large, mobile, serpentine thrombus in the right atrium. This is a thrombus-in-transit, a true medical emergency associated with high mortality. The immediate question is not one of diagnosis, but of intervention: what is the most appropriate initial therapy to prevent imminent cardiovascular collapse? For this specific, high-risk presentation, the American College of Radiology (ACR) Appropriateness Criteria rate multiple aggressive interventions, including Anticoagulation, Catheter-directed therapy, and Surgical embolectomy, as ‘Usually appropriate’, reflecting the critical nature of the decision.

Who Fits This Clinical Scenario for a Right Atrial Thrombus in Transit?

This guidance applies to a very specific and critically ill patient population: an adult with an acute thromboembolism that has been directly visualized within the right atrium (a “thrombus-in-transit”) who is also experiencing sustained hypotension for more than 15 minutes. This clinical picture signifies high-risk (massive) pulmonary embolism with obstructive shock. The presence of the thrombus in the right heart is a key differentiator, as it represents a clot caught between its origin in the deep venous system and its destination in the pulmonary arteries, with a high risk of fragmentation and further embolization.

This workflow is not intended for patients who may present similarly but lack a key criterion:

  • Patients with massive PE but no visualized thrombus-in-transit: An adult with extensive bilateral pulmonary emboli and sustained hypotension, but without a clot seen in the right heart, falls under a different, though related, management pathway.
  • Hemodynamically stable patients with right heart strain: A patient with acute pulmonary emboli and evidence of right heart strain (e.g., RV/LV ratio greater than 0.9 on CT Angiography) but who remains normotensive is considered to have submassive PE. The management strategy for this group is distinct and often less aggressive.
  • Hemodynamically stable patients with a large clot burden: An adult with a large saddle pulmonary embolism who is normotensive and has no evidence of right heart strain or biomarker elevation has a lower immediate risk profile, and initial therapy is typically anticoagulation alone.

Correctly identifying your patient within this specific high-risk scenario is the crucial first step in initiating life-saving therapy.

What Diagnoses Are You Working Up in This Scenario?

In this emergent situation, the primary diagnosis of acute thromboembolism is often already established or strongly suspected based on imaging. The clinical workup is focused on characterizing the immediate, life-threatening consequences of the thrombus-in-transit and guiding the choice of intervention.

High-Risk (Massive) Pulmonary Embolism: This is the principal diagnosis. The combination of a visible thrombus in the right heart and sustained hypotension defines this as the most severe category of PE. The thrombus is actively causing or is about to cause catastrophic obstruction of the right ventricular outflow tract, leading to cardiovascular collapse. The immediate goal is to alleviate this obstruction.

Obstructive Shock: The sustained hypotension is the clinical sign of obstructive shock. The right ventricle is failing because it cannot pump blood past the embolic obstruction into the pulmonary circulation. This leads to decreased blood flow returning to the left ventricle, reduced cardiac output, and systemic hypoperfusion. Differentiating this from other shock etiologies (e.g., cardiogenic, septic) is critical, and the visualization of a right atrial thrombus makes PE the definitive cause.

Impending Paradoxical Embolism: A thrombus-in-transit poses a dual threat. While the primary concern is embolization to the lungs, there is a significant risk of paradoxical embolism to the systemic arterial circulation if a patent foramen ovale (PFO) or other intracardiac shunt exists. A clot passing from the right atrium to the left atrium can travel to the brain, causing a massive ischemic stroke. This possibility dramatically raises the stakes and influences the choice between therapies.

Acute Right Ventricular (RV) Failure: The underlying pathophysiology of obstructive shock in this context is acute, fulminant RV failure. The normally low-pressure right ventricle cannot generate the force needed to overcome the sudden, severe increase in afterload. This leads to RV dilation, tricuspid regurgitation, and a downward spiral of decreasing cardiac output. All therapeutic interventions are aimed at rapidly reducing RV afterload to rescue the failing ventricle.

Why Are Multiple Therapies ‘Usually Appropriate’ for a Right Atrial Thrombus in Transit?

The ACR designates Anticoagulation, Catheter-directed therapy, and Surgical embolectomy as ‘Usually appropriate’ for this scenario. This unusual equivalence among multiple invasive options highlights the extreme risk of the condition and the lack of a single universally superior treatment. The optimal choice depends heavily on local institutional expertise, patient-specific factors, and contraindications.

Anticoagulation is the foundational therapy and is rated ‘Usually appropriate’. It should be initiated immediately upon suspicion, often with an intravenous unfractionated heparin bolus and infusion. While it does not dissolve the existing clot, it prevents further clot formation and propagation, stabilizing the situation and allowing the body’s own fibrinolytic system to begin work. However, in the setting of obstructive shock, anticoagulation alone is often insufficient to rapidly reverse the hemodynamic collapse.

Catheter-directed therapy is also ‘Usually appropriate’. This involves percutaneously advancing catheters into the right heart and pulmonary arteries to directly address the thrombus. Techniques can include aspiration thrombectomy (using suction to remove the clot), fragmentation, and/or the infusion of low-dose thrombolytic drugs directly into the clot. This approach can provide rapid relief of RV outflow obstruction and is less invasive than open-heart surgery, making it a strong option for patients who are poor surgical candidates.

Surgical embolectomy is the third option rated ‘Usually appropriate’. This is an open-heart procedure requiring cardiopulmonary bypass, where a surgeon directly visualizes and removes the thrombus from the right atrium and pulmonary arteries. It offers the most definitive clot removal and can simultaneously address a PFO if one is present, eliminating the risk of paradoxical embolism. It is often favored in centers with experienced cardiac surgical teams, especially for patients with large, mobile clots or contraindications to thrombolysis.

In contrast, other therapies are rated lower for this specific presentation:

  • Systemic thrombolysis is rated ‘May be appropriate’. While it can be effective for massive PE, it carries a significant risk of major bleeding, including intracranial hemorrhage. Furthermore, there is a theoretical concern that the lytic agent could cause the large, mobile right atrial thrombus to fragment, leading to catastrophic bilateral pulmonary emboli before it can be dissolved.
  • Extracorporeal membrane oxygenation (ECMO) is also rated ‘May be appropriate’. ECMO can be a life-saving bridge to definitive therapy by providing temporary cardiac and respiratory support. However, it is not a treatment for the clot itself and is used to stabilize a patient who is too unstable to tolerate transport or a definitive procedure like surgery or catheter-directed therapy.

What’s Next After Intervention? Downstream Workflow

The immediate post-intervention period is critical and requires intensive monitoring, typically in an intensive care unit (ICU). The downstream workflow depends on the success of the initial therapy and the patient’s hemodynamic response.

If the intervention is successful (e.g., clot removed, hemodynamics improve): The patient will be weaned from vasopressors and mechanical ventilation as tolerated. The focus shifts to standard post-PE management. A therapeutic anticoagulation regimen (often transitioning from a heparin drip to an oral anticoagulant) is essential to prevent recurrence. A comprehensive workup for the underlying cause of the VTE should be performed, including screening for hypercoagulable states or malignancy if indicated. Follow-up imaging, such as a transthoracic echocardiogram, is performed to assess for recovery of right ventricular function.

If the initial intervention is unsuccessful or partially successful: If the patient remains in shock despite the initial therapy (e.g., persistent hypotension after catheter-directed therapy), escalation is required. This may involve rescue surgical embolectomy or the initiation of ECMO as a bridge to further intervention or recovery. A multidisciplinary discussion involving interventional radiology, cardiac surgery, and critical care is paramount in these refractory cases.

If the patient stabilizes but has significant residual clot: The decision for further intervention versus continued anticoagulation and observation is complex. The patient may transition to a submassive PE pathway, where the risk-benefit ratio of additional invasive procedures must be carefully weighed against the risks of bleeding with continued anticoagulation.

Pitfalls to Avoid (and When to Get Help)

Managing a thrombus-in-transit is a high-stakes endeavor where delays or missteps can be fatal. Key pitfalls to avoid include:

  • Delaying Therapy: Time is critical. Indecision or delays in activating the appropriate response team (e.g., PERT, interventional radiology, or cardiac surgery) can lead to irreversible cardiovascular collapse.
  • Underestimating the Risk of Paradoxical Embolism: Failing to consider the potential for a PFO and subsequent stroke can lead to suboptimal therapeutic choices. If surgical embolectomy is chosen, intraoperative PFO closure should be performed.
  • Relying Solely on Anticoagulation: In a patient with sustained hypotension from a thrombus-in-transit, anticoagulation alone is rarely sufficient for rapid hemodynamic improvement. An advanced, definitive therapy is almost always required.
  • Choosing a Therapy Unavailable or Unfamiliar at Your Institution: The “best” therapy is often the one that can be delivered most quickly and expertly at your center. Attempting a complex catheter-based procedure without an experienced team can be more dangerous than transferring the patient for surgery.

If the patient continues to deteriorate despite initial vasopressor support and anticoagulation, immediate escalation to a multidisciplinary team, such as a Pulmonary Embolism Response Team (PERT), is essential to facilitate rapid, coordinated decision-making.

Related ACR Topics and Tools

This article covers a single, critical scenario in the management of acute pulmonary embolism. For a comprehensive overview of all related clinical variants and their respective ACR ratings, please consult our parent guide. For additional resources on imaging criteria, protocols, and radiation safety, the following GigHz tools are available.

Frequently Asked Questions

Why are three different, major interventions all rated ‘Usually appropriate’ for this scenario?

The ACR rating reflects the extreme severity and high mortality of a thrombus-in-transit with shock. There is no single, universally superior therapy proven in randomized controlled trials. The best choice among surgical embolectomy, catheter-directed therapy, and anticoagulation (as a bridge or baseline) depends on the patient’s specific clinical status, contraindications, and, critically, local institutional expertise and resource availability. A rapid, multidisciplinary team approach is key.

Should I start with systemic thrombolysis for a patient with a right atrial thrombus and shock?

Systemic thrombolysis is rated ‘May be appropriate’ by the ACR, a step below other advanced therapies. While it can be life-saving in massive PE, there is a theoretical risk that the lytic agent could cause the large, mobile thrombus to fragment, resulting in catastrophic bilateral pulmonary artery occlusion. Therefore, therapies that offer more direct clot removal, like surgery or catheter-directed therapy, are often preferred if available.

What is the role of a Pulmonary Embolism Response Team (PERT) in this specific scenario?

A PERT is invaluable in this situation. A thrombus-in-transit with shock requires rapid, coordinated input from multiple specialties, including emergency medicine, critical care, cardiology, interventional radiology, and cardiac surgery. A PERT facilitates an immediate conference to weigh the risks and benefits of each available therapy and mobilize the necessary resources, minimizing delays and optimizing the treatment plan for the individual patient.

If the patient has a known PFO, does that change the choice of therapy?

Yes, a known patent foramen ovale (PFO) significantly increases the risk of a paradoxical embolism and stroke. This finding often strengthens the argument for surgical embolectomy, as the surgeon can remove the clot and close the PFO during the same procedure, definitively eliminating both the pulmonary and systemic embolic threats. If surgery is not an option, meticulous technique during any catheter-based procedure is required to avoid pushing the clot across the PFO.

Is anticoagulation alone ever sufficient for a thrombus-in-transit with sustained hypotension?

No, in a patient with sustained hypotension (obstructive shock) caused by a thrombus-in-transit, anticoagulation alone is considered insufficient. While it is a critical first step to prevent clot propagation, it will not resolve the mechanical obstruction quickly enough to reverse the shock state. An advanced therapy aimed at rapid clot removal or reduction is required.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026